rs886039373
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP2PP3PP5_Very_Strong
The NM_001127644.2(GABRA1):c.641G>A(p.Arg214His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001127644.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 19 Pathogenic:5
- -
- -
- -
ACMG evidence PS2, PM2, PP2, PP3, PP5 -
PS3, PS4, PM2, PP3 -
not provided Pathogenic:2
Published functional study demonstrates a damaging effect due to impaired GABA-A receptor inhibitory function (Johannesen et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27353043, 30185235, 32238909, 27535533, 27521439) -
GABRA1: PM2, PM5, PM6, PS4:Moderate, PP2, PP3, PS3:Supporting -
Idiopathic generalized epilepsy;C1970160:Epilepsy, childhood absence 4;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 214 of the GABRA1 protein (p.Arg214His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Dravet syndrome-like phenotype (PMID: 27353043). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 265162). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GABRA1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GABRA1 function (PMID: 27353043). For these reasons, this variant has been classified as Pathogenic. -
Developmental and epileptic encephalopathy, 19;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 Pathogenic:1
PM2_Supporting+PP2+PS4_Moderate+PM6_Strong+PM1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at